MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q2 EPS of ($0.18), $0.05 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.